These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 15144854

  • 1. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

  • 2. Initiation and synergistic fibrillization of tau and alpha-synuclein.
    Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM.
    Science; 2003 Apr 25; 300(5619):636-40. PubMed ID: 12714745
    [Abstract] [Full Text] [Related]

  • 3. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE.
    J Mol Biol; 2002 Jan 25; 315(4):799-807. PubMed ID: 11812148
    [Abstract] [Full Text] [Related]

  • 4. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
    Kumar S, Sarkar A, Sundar D.
    Biochem Biophys Res Commun; 2009 Sep 18; 387(2):305-9. PubMed ID: 19580781
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR.
    Biochemistry; 2005 May 31; 44(21):7818-29. PubMed ID: 15909996
    [Abstract] [Full Text] [Related]

  • 7. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1101-18. PubMed ID: 10434313
    [Abstract] [Full Text] [Related]

  • 8. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
    Du HN, Tang L, Luo XY, Li HT, Hu J, Zhou JW, Hu HY.
    Biochemistry; 2003 Jul 29; 42(29):8870-8. PubMed ID: 12873148
    [Abstract] [Full Text] [Related]

  • 9. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 29; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 10. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M, Wolozin B.
    Exp Neurol; 2004 Jun 29; 187(2):235-9. PubMed ID: 15144849
    [No Abstract] [Full Text] [Related]

  • 11. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, Ikeda K, Uéda K, Kuroda S.
    Acta Neuropathol; 2002 Oct 29; 104(4):333-41. PubMed ID: 12200618
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb 29; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 15. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
    Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, Crowther RA, Goedert M.
    FEBS Lett; 2004 Oct 22; 576(3):363-8. PubMed ID: 15498564
    [Abstract] [Full Text] [Related]

  • 16. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R, Ihara M.
    Acta Neuropathol; 2006 Dec 22; 112(6):681-9. PubMed ID: 16957925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA.
    Neurobiol Dis; 2005 Apr 22; 18(3):492-8. PubMed ID: 15755676
    [Abstract] [Full Text] [Related]

  • 19. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.
    Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, Trojanowski JQ.
    Acta Neuropathol; 2002 Jul 22; 104(1):7-11. PubMed ID: 12070658
    [Abstract] [Full Text] [Related]

  • 20. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE, Lesnick TG, Lincoln SJ, Strain KJ, de Andrade M, Bower JH, Ahlskog JE, Rocca WA, Farrer MJ, Maraganore DM.
    Ann Neurol; 2005 Mar 22; 57(3):439-43. PubMed ID: 15732111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.